Results 191 to 200 of about 24,713 (214)

PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma [PDF]

open access: yes, 2017
Hassan, Anjum   +5 more
core   +1 more source

Brain intratumoural astatine-211 radiotherapy targeting syndecan-1 leads to durable glioblastoma remission and immune memory in female mice. [PDF]

open access: yesEBioMedicine
Roncali L   +13 more
europepmc   +1 more source

Endothelial glycocalyx damage marker syndecan-1 during hypothermic oxygenated machine perfusion of donor grafts facilitates prediction of early allograft dysfunction after liver transplantation. [PDF]

open access: yesHepatobiliary Surg Nutr
Rauter L   +11 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Syndecan-1 in liver pathophysiology

American Journal of Physiology-Cell Physiology, 2022
Syndecan-1 (SDC-1) is a heparan sulfate (HS)/chondroitin sulfate proteoglycan (PG) of the cell surface and the extracellular matrix (ECM), which regulates a broad spectrum of physiological and pathological processes such as cell proliferation, migration, inflammation, matrix remodeling, wound healing, and tumorigenesis. Syndecan-1 represents the major
Andrea Reszegi   +4 more
openaire   +2 more sources

Syndecan-1 in B lymphoid malignancies

Annals of Hematology, 2002
Syndecans are heparan sulfate-bearing proteoglycans that are found on the surface of most cells. Syndecan-1 is expressed predominantly on epithelia, but is also present on pre-B cells and plasma cells. The syndecans act to bind various effector molecules via their heparan sulfate chains, including both soluble and insoluble molecules within the ...
R D, Sanderson, M, Børset
openaire   +2 more sources

Impaired arteriogenesis in syndecan-1−/− mice

Journal of Surgical Research, 2015
Collateral artery development (arteriogenesis) is an important compensatory response to arterial occlusion caused by atherosclerosis. The heparan sulfate proteoglycan syndecan-1 (sdc1) has previously been shown to affect the response to arterial injury but has yet been studied in arteriogenesis.
Gale L, Tang, Kevin, Weitz
openaire   +2 more sources

Targeting syndecan-1: new opportunities in cancer therapy

American Journal of Physiology-Cell Physiology, 2022
Syndecan-1 (SDC1, CD138) is one of the heparan sulfate proteoglycans and is essential for maintaining normal cell morphology, interacting with the extracellular and intracellular protein repertoire, as well as mediating signaling transduction upon environmental stimuli.
Zecheng Yang   +3 more
openaire   +2 more sources

[Construction and identification of mouse wildtype-syndecan-1 and unshedding-syndecan-1 expressing vector].

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2012
To construct the expressing vector pcDNA3.0- wildtype-syndecan-1(WT-sdc1) and pcDNA3.0-unshedding-syndecan-1(uS-sdc1), and to explore the expression in vitro.(1)The mouse WT-sdc1 DNA was successfully amplified by PCR and then cloned into pcDNA3.0. uS-sdc1 was construct by Gene splicing by overlap extension- PCR on the basis of WT-sdc1.
Jun, Liu   +7 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy